検索して下のLife Raft Groupの文献をみつけました。 http://www.liferaftgroup.org/gist_initial_treatment.html#neoadjuvant “According the JNCCN guidelines, "For both large tumors and poorly positioned small GISTs that are considered marginally resectable on technical grounds, neoadjuvant imatinib is recommended.”